News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Belldegrun Arie
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/24/2023 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 1,282,976 shares
@ $0
Granted 994,800 options to buy
@ $5.04, valued at
$5M
|
|
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/16/2022 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 160,000 options to buy
@ $5, valued at
$800k
|
|
| 09/02/2022 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 3,241 options to buy
@ $5, valued at
$16.2k
|
|
| 06/29/2022 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 34,000 options to buy
@ $3.53, valued at
$120k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $7.06, valued at
$70.6k
|
|
| 04/01/2022 |
4/A
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Disposed of 4,710,120 shares
@ $0
Acquired 4,710,120 shares
@ $0 |
|
| 03/31/2022 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Disposed of 4,710,121 shares
@ $0
Acquired 4,710,121 shares
@ $0 |
|
| 03/28/2022 |
3/A
| Belldegrun Arie (Director) has filed a Form 3/A on Ginkgo Bioworks Holdings, Inc. |
| 03/25/2022 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 1,458,333 options to buy
@ $9.69, valued at
$14.1M
|
|
| 02/17/2022 |
SC 13G/A
| Belldegrun Arie reports a 6.1% stake in KRONOS BIO, INC. |
| 02/14/2022 |
SC 13G/A
| Belldegrun Arie reports a 5% stake in ALLOGENE THERAPEUTICS, INC. |
| 01/14/2022 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Bought 155,039 shares
@ $12.6, valued at
$2M
|
|
| 09/20/2021 |
3
| Belldegrun Arie (Director) has filed a Form 3 on Ginkgo Bioworks Holdings, Inc. |
| 06/23/2021 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 20,600 options to buy
@ $24.18, valued at
$498.1k
|
|
| 06/09/2021 |
4/A
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 3,241 options to buy
@ $5, valued at
$16.2k
|
|
| 06/09/2021 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $17.98, valued at
$179.8k
|
|
| 05/25/2021 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Exercised 379,066 options to buy
@ $18.22, valued at
$6.9M
|
|
| 04/22/2021 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 3,241 options to buy
@ $5, valued at
$16.2k
|
|
| 03/30/2021 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 53,635 shares
@ $0
Granted 199,223 options to buy
@ $33.78, valued at
$6.7M
|
|
| 02/12/2021 |
SC 13G/A
| Belldegrun Arie reports a 4.6% stake in ALLOGENE THERAPEUTICS, INC. |
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/10/2020 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $28.24, valued at
$282.4k
|
|
| 06/04/2020 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Bought 40,000 shares
@ $47, valued at
$1.9M
Bought 106,382 shares
@ $47, valued at
$5M
|
|
| 03/20/2020 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 379,066 options to buy
@ $18.22, valued at
$6.9M
|
|
| 02/13/2020 |
SC 13G/A
| Belldegrun Arie reports a 6% stake in ALLOGENE THERAPEUTICS, INC. |
| 02/13/2020 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 06/05/2019 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 10,000 options to buy
@ $34.83, valued at
$348.3k
|
|
| 05/15/2019 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Disposed of 598,935 shares
@ $0
Acquired 13,413 shares
@ $0 |
|
| 04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2019 |
4
| Belldegrun Arie (Director) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Exercised 128,000 options to buy
@ $4.02, valued at
$514.6k
|
|
| 03/15/2019 |
4
| Belldegrun Arie (Director) has filed a Form 4 on Allogene Therapeutics, Inc.|
Txns:
| Granted 115,333 shares
@ $0
Granted 195,133 options to buy
@ $26.89, valued at
$5.2M
|
|
|
|
|